US 10836763
5 to 7 membered heterocyclic amides as JAK inhibitors
granted A61KA61K9/0073A61P
Quick answer
US patent 10836763 (5 to 7 membered heterocyclic amides as JAK inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K9/0073, A61P, A61P11/00, A61P11/06